1. Hirsch IB. Hypoglycemia and the hypoglycemic unawareness syndrome. Diabetes Technol Ther. 2000; 2(Suppl 1):S81–7.
Article
2. Korean Diabtets Association. Tretment guideline for diabetes 2011. Diabetes Metab J. 2011; 12(Suppl 1):46–9.
3. Ginsberg BH. The FDA panel advises approval of the first continuous glucose sensor. Diabetes Technol Ther. 1999; 1:203–4.
Article
4. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359:1464–76.
5. Kestilä KK, Ekblad UU, Rönnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract. 2007; 77:174–9.
Article
6. Jung SH, Kang IK, Park CY, Ryu MS, Woo JT, Kim SW, Kim JW, Kim YS. Continuous glucose monitoring is needed to detect unrecognized hypoglycemic event in diabetic patients with stroke. Korean Clin Diabetes. 2002; 3:140–51.
7. Yoo HJ, An HG, Park SY, Ryu OH, Kim HY, Seo JA, Hong EG, Shin DH, Kim YH, Kim SG, Choi KM, Park IB, Yu JM, Baik SH. Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2008; 82:73–9.
Article